Literature DB >> 10230595

Scleromalacia following trabeculectomy with intraoperative mitomycin C.

Y A Akova1, F Koç, I Yalvaç, S Duman.   

Abstract

PURPOSE: To report the development of scleromalacia in pediatric age as a complication of trabeculectomy with the adjunctive use of intra-operative mitomycin C. PATIENTS: Reported are 2 patients who developed scleromalacia following trabeculectomy combined with intra-operative 0.4 mg/ml mitomycin C application for 5 minutes for refractory glaucoma in aphakic bullous keratopathy and penetrating keratoplasty.
RESULTS: Scleromalacia localised in the surgical area developed in 2 young patients. Scleromalacia remained stable in both patients after 6 and 24 months follow-ups.
CONCLUSIONS: It is suggested that this procedure be done more selectively, especially in young patients, with a shorter application time and using a lower concentration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230595     DOI: 10.1177/112067219900900110

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

Review 1.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

2.  Neovascularization of angle following trabeculectomy augmented with mitomycin-C.

Authors:  Wesam Shamseldin Shalaby; Reza Razeghinejad
Journal:  Oman J Ophthalmol       Date:  2021-02-27

Review 3.  A review of the efficacy of mitomycin C in glaucoma filtration surgery.

Authors:  Ahmed Al Habash; Leyla Ali Aljasim; Ohoud Owaidhah; Deepak P Edward
Journal:  Clin Ophthalmol       Date:  2015-10-20

4.  [Displacement of a STARflo glaucoma drainage implant with accompanying complications].

Authors:  S Schrittenlocher; A Doulis; K R Koch; A Lappas; L Altay; A-M Lentzsch; C Cursiefen; B Bachmann; V Prokosch-Willing; T Dietlein
Journal:  Ophthalmologe       Date:  2021-04-21       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.